Table 1.
Differentially abundant proteins in the Super-pathway of Cholesterol Biosynthesis network
| Protein name | YN1/Ctrl | CHIR/Ctrl |
|---|---|---|
| Acat1 | −1.22619 | −0.1422 |
| Lbr | −1.11595 | −1.03956 |
| Hadhb | −1.0669 | −1.09432 |
| Hadha | −1.0977 | −1.07973 |
| Hmgcr | −1.34085 | −1.27025 |
| Hsd17b7 | −1.47669 | −1.47494 |
| Sqle | −1.44067 | −1.53392 |
| Msmo1 | −1.54533 | −1.46496 |
| Fdft1 | −1.51828 | −1.56956 |
| Lss | −1.58772 | −1.52997 |
| Tm7sf2 | −1.60068 | −1.54865 |
| Nsdhl | −1.58253 | −1.67584 |
| Dhcr7 | −1.63414 | −1.69493 |
| Fdps | −1.58861 | −1.78847 |
| Acat2 | −1.74065 | −1.8132 |
| Cyp51a1 | −1.78618 | −1.87085 |
| Mvk | −1.84842 | −1.90875 |
| Pmvk | −1.89759 | −2.02919 |
| Idi1 | −2.00878 | −2.01207 |
| Mvd | −2.03588 | −2.03867 |
| Hmgcs1 | −1.88482 | −2.29426 |
The proteomic data was filtered to include proteins associated with the Mevalonate/cholesterol pathway. Protein abundances are represented as the ratio of the grouped abundance in the treatment groups to the grouped abundance in the control media (YN1/Ctrl and CHIR/Ctrl).